could inhibit growth if a heavy inoculum were used. As Figure  2 illustrates, however, our preparation exhibited increased growth with a larger inoculum. Detailed performance specifications are given for a specific and sensitive liquid-chromatographic assay for aspirin, salicylic acid, and salicyluric acid in plasma. The sensitivity of this method for aspirin (50 tg/L) is 10-fold that of previous methods, so that concentrations of aspirin in plasma can now be followed for about four or five half-lives after the peak plasma concentration arising from a single 650-mg dose. In addition, this assay is as sensitive for salicylic and salicyluric acid in plasma as any hitherto. A modification permits measurement of gentisic acid, salicylic acid, and salicyluric acid in urine; further modifications allow indirect measurement of conjugated gentisate and salicylate in urine.
AddItIonal Keyphrases:pharmacokinetics drug assay
Reports on the pharmacokinetics of aspirin and salicylate and their metabolites continue to appear in the literature 
Materials and Methods

Apparatus.
Our chromatographic Procedure for urine samples.
Increase the concentration of the internal standard, m-hydroxybenzoic acid, to 100 mg/L;
and We divide all standard curves into two ranges, to avoid undue weight being given to points at high concentrations.
Detailed standardization specifications are shown in Table 1 . Table 1 shows linearity, precision, and accuracy specifications for the assay of aspirin, salicylic acid, and salicyluric acid in plasma and for the assay of salicylic, salicyluric, and gentisic acids and "total" salicylates (i.e., salicylic acid, its salts and conjugates) and "total" gentisates in urine. Of the conjugates, only salicyluric acid was available, so specifications for assay of "total" salicylates and "total" gentisates were determined by the assay procedure leadingto measurement of the conjugates but using instead standards of salicylic acid and gentisic acid. Specifications for the assay including conjugates should be similar if hydrolysis is complete. We investigated completeness of hydrolysis, using salicyluric acid, which as an amide conjugate should be no more readily hydrolyzed than the other expected conjugates of salicylic or gentisic acids.
Results
Hydrolysis of conjugates was judged to be complete by disappearance of the peak corresponding to salicyluric acid in unhydrolyzed urine, and by the quantitative recovery as salicylic acid of added salicyluric acid ( Table 2 ). Figure 1 shows chromatograms from a subject's plasma samples collected before and 4 h after his taking a 650-mg oral dose of aspirin. Figure 2 shows the time course of the concentrations of aspirin, salicylic acid, and salicyluric acid in his plasma.
The plasma assay has been used in a study measuring acetylsalicylic, salicylic, and salicyluric acid concentrations in 18 subjects on two occasions. a Uneerlty: for plasma, mean ± SD from 15 standard curves; for iy&olyzed urine, from 1 standwd cuve; for hydrolyzed sine, from 2 standard ctsves. 5Preclsn: for plasma, between day (n = 15)/within day (n = 6); for unhydrolyzed sIne, mean ± SD of ratio of 2 determinatIons in each of 12 samples; for hydrolyzed urine, between day (n = 4). C Accuracy: for plasma, % bias of 15 determinatIons on 15 days; for hydrolyzed wine, % bias of 4 determInations on 4 days. All urine concentrations expressed as the equivalent concentration of salicylic acid.
Amount measured after hydrolysis treatment, mg/I a Urine assayd containing aspirin were injected into the HPLC within 2 hand standards and samples were treated as uniformly as possible.
Aspirin concentrations appeared
to decrease even if samples were re-assayed after frozen storage, with an average 3% decline (range: 13% decline to 7% apparent increase) for nine samples reassayed after one to five days of storage at -20#{176}C and an average 20% decline (range: 18% to 20%) for three samples re-assayed after 11 days at -20 #{176}C.
For analysis of urine the detection wavelength was changed from that used for plasma, to optimize sensitivity for gentisic acid in urine (at the expense of acetylsalicylate sensitivity).
With the decreased acetonitrile concentration in the eluent used for the urine assay, compounds elute a little more slowly than during plasma assays, with typical retention times of 5.3, 6.7, 8.3, and 15.5 mm for gentisic, m-hydroxybenzoic, salicyluric, and salicylic acids, respectively. The maximum interference with salicylic acid in six blank urines was equivalent sitive salicylic acid methods previously described (7, 8) . Most of the previous methods include a drying step and therefore require inconvenient precautions to avoid inaccuracies due to sublimation of salicylic acid. (Even at 20 #{176}C we have observed substantial loss of salicylic acid with evaporation methods.) The method described here does not involve any drying but uses a back-extraction instead. Another recently reported method (8) also avoids a drying step, but unfortunately does not include precautions to avoid artificially high salicylic acid values resulting from hydrolysis of aspirin.
Several other liquid-chromatographic methods for measurement of salicyluric acid in plasma are available (6) (7) (8) (9) , but specifications are not given for samples with concentrations as low as in the present method. Other methods allow the simultaneous measurement of gentisic acid in plasma (6, 8) . The method of Amick and Mason (6) allows for simultaneous measurement of acetylsalicylic, salicylic, salicyluric, and gentisic acids in plasma by monitoring both fluorescence and ultraviolet absorbance. We believe that the method described here might also be modified to include gentisic acid in plasma, either by monitoring ultraviolet absorbance at two wavelengths or by monitoring ultraviolet absorbance and fluorescence.
